Member Info for Mikey279

Yep looks like it flushed the overhang out...surprised it didn't do 100%+ on the Vatic RNS, but maybe a slow re-rate from now

Affidx is priced out… so no point thinking we track them

So what is fair value… with Vatic TT complete and PRODUCTION underway and another £8m likely receipt within the next month or so…. Probably around 40-50p…. Before confirmation of DHSC payment, when EUA comes through it’s well into the £s

IMO

We've already seen how fast this can move... think it was 85p or so on the bio test...,

We should comfortably be above placing price right now with a test in production (with massive upscale potential) and DHSC payment expected soon

DHSC/FDA EUA could land anytime and would be worth 50p a piece IMO, (if you consider the upscaling potential with the money, cash runway for another year etc etc), and then later in the year if Affidx comes online again or other contracts land...it'll just disappear like BBI

One of, if not the cheapest share on the market at £14m....

IMO

Taken a large amount here.... dirt cheap

IPO'd at £100m
Placing at 25p but only due to DHSC issue... don't think they would've diluted otherwise
Affidx (not dead) but replaced by Vatic which is now live
Director skin in game
BBI sold for £400m
Testing industry only going to grow and Covid still around
Significant investment in infrastructure and ready to produce
Cashed up for the year

Catalysts
DHSC payment
Emergency FDA

Looks stupidly cheap to me at only £14m so should expect a re-rate, the catalysts would take it well above IPO levels IMO if Vatic market well, a 10-20x + opportunity from these levels

All IMO

What date are we looking are for results?

By far the cheapest share in the market for pipeline IP and progress....should easily be £300-500m mcap currently IMO

You don't whack in a few mil at £1.10 as directors if you think its worth 39p....

It'll re-rate just a matter of when

So in theory we just need to up our holding by 10% to flush SO ;)

It's a sell IMO, how it usually works is that e.g. SO would have a price with broker when it was 57p to take the rest at 41p.... MM's would take days/weeks/months to churn through it and release a print when it's finished

oh right another 700k at 50p yesterday....just RNS'd

Nice reversal here... CEO only bought nearly £3m worth at 96p a few months back...

fair enough....I was going for around 10% but we can meet half way 7.5....either way looks v close now, those late prints can only be SO

not sure on this math.... but 5% of 3.6m is only 180k shares.... that is nothing on the SP drag, you'd imagine it's parcels of 10-20% of the shares that MM's are churning through based on daily volume and they'd unleash it into any liquidity

On another note, today was the first day we saw big prints since RNS day where SO dumped a load/shorts were opened....so they're either flushing the final bits now or letting the shorts out

Time will tell

IMO

Crazy how this is the most undervalued share in the entire AIM after recent news of which nothing has been priced in for a year in due to a seller deciding to drip feed 1% a month into any volume....funding and cash burn is as per normal for any biopharm, nonetheless cash run until Q4 and its not like they will raise at these levels when they know SO is on fumes (you'd imagine it'll be in Q3/Q4 for any raise)

The directors bought heavy at £1.10, you have broker notes at £3.50-£4 - that's almost 10x which is unheard of

£74m for the entire pipeline, IP and one of the few microbiome successes in the world...not to mention Merck as a SH, the various partnerships etc

Why this isn't in the £300-500m mcap range is when SO is well under 2% is beyond me - although I do admit it was a bargepole stock when i saw the 10% 9% 8% 7% SO TR1s, but after the keytruda Part 2 success (when part A took us to £1.80) makes it the biggest risk reward play that exists

All IMO

The red autos have also dried up...

Wasn't the broker note £3 or so on jade and topaz?

FOMO will kick in when SO's last few shares clear and we have a year of RNS to price in

Cash until Q4 so plenty of time to get into the £s and do a raise in Q3, which will largely be on stateside anyway.

800k shorts to close too

IMO ;)

check out the volumes since last TR1....SO on fumes/out? SP action will determine

Volume from 18/3/21 - 23/3/21 - around 42m

SO - 3.84% to 2% = 3.3m dumped, 3.6m remaining

Volume from 24/3/22 to now - around 39.5m

Pretty close now....the rest is just noise, fundraise will probably be in H2 but once our 1 years worth of RNS has been priced in, nothing unexpected in todays results